Cover Image
市場調查報告書

生命科學設備的全球市場的預測 ∼2021年:層析法、流式細胞儀、光譜學、PCR、顯微鏡

Life Science Instrumentation Market by Technology (Chromatography, Flow Cytometer, Spectroscopy, PCR, Microscopy), End User (Pharmaceutical & Biotechnology Companies, CROs, Hospitals), Application - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 366851
出版日期 內容資訊 英文 321 Pages
訂單完成後即時交付
價格
Back to Top
生命科學設備的全球市場的預測 ∼2021年:層析法、流式細胞儀、光譜學、PCR、顯微鏡 Life Science Instrumentation Market by Technology (Chromatography, Flow Cytometer, Spectroscopy, PCR, Microscopy), End User (Pharmaceutical & Biotechnology Companies, CROs, Hospitals), Application - Global Forecast to 2021
出版日期: 2016年08月11日 內容資訊: 英文 321 Pages
簡介

全球各種生命科學設備的市場預計從2016年到2021年以6.8%的年複合成長率發展,2021年成長到645億2000萬美元的規模。醫藥品企業的R&D支出的擴大,對食品安全性的意識擴大,生命科學研究的公共資金、民間資金的可用性的擴大,分析設備相關技術的持續發展等要素促進該市場的成長。

本報告提供全球各種生命科學設備的市場調查,市場概要,產業結構與價值鏈,市場成長的各種影響因素與市場機會分析,技術、終端用戶產業、用途、地區等各種區分趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

  • 簡介
  • 目前方案
  • 未來展望
  • 總論

第4章 重要考察

  • 全球市場概要
  • 地區市場分析:各技術
  • 各用途市場分析、預測
  • 地區概要
  • 生命週期分析:各地區

第5章 生命科學設備的全球市場:概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 生命科學設備的全球市場:產業趨勢

  • 簡介
  • 價值鏈分析
  • 市場指標
  • 產業趨勢
  • 波特的五力分析

第7章 生命科學設備的全球市場:各技術

  • 光譜學
    • 推進因素
    • 障礙
    • 各類型市場
      • 分子光譜學
      • 質譜分析法
      • 原子光譜學
  • 層析法
    • 推進因素
    • 障礙
    • 各類型市場
      • 液體層析法 (LC) 系統
      • 氣相層析法 (GC) 系統
      • 超臨界流體層析法 (SFC) 系統
      • 薄層層析法 (TLC) 系統
    • 市場企業的市場佔有率
  • 顯微鏡
    • 推進因素
    • 障礙
    • 各類型市場
      • 光學顯微鏡
      • 電子顯微鏡
      • 掃描探針顯微鏡
      • 共聚焦顯微鏡
  • PCR
    • 推進因素
    • 障礙
    • 各類型市場
      • qPCR
      • 數位PCR (dPCR)
  • 流式細胞技術
    • 推進因素
    • 障礙
    • 各類型市場
      • 細胞為基礎
      • 以微珠為基礎
    • 市場企業的市場佔有率
  • 免疫檢測
    • 推進因素
    • 障礙
    • 市場企業的市場佔有率
  • 液體處理、機器人工學
    • 推進因素
    • 障礙
    • 液體處理:各類型市場
      • 自動液體分注儀
      • 手動液體處理
    • 獨立式機器人:各類型市場
      • 機械臂
      • 追蹤機器人系統
  • 離心分離
    • 推進因素
    • 障礙
    • 各類型市場
      • 微量離心機
      • 通用離心機
      • 地板間隔離心機
      • 超離心機
    • 市場企業的市場佔有率
  • 電泳
    • 推進因素
    • 障礙
    • 各類型市場
      • 凝膠電泳系統
      • 毛細管電泳法系統
    • 市場企業的市場佔有率
  • 細胞測量
    • 推進因素
    • 障礙
    • 各類型市場
      • 自動
      • 血球計數器、手動
    • 市場企業的市場佔有率
  • 次世代定序 (NGS)
    • 推進因素
    • 障礙
    • 市場企業的市場佔有率
  • 西方墨點法
    • 推進因素
    • 障礙
    • 各類型市場
      • 半自動
      • 自動
      • 手動
    • 市場企業的市場佔有率
  • 其他
    • 實驗室用製冷器
    • 加熱殺菌
    • 微孔盤系統
    • 實驗室用天平
    • 比色計
    • 培養箱
    • 通風食物

第8章 生命科學設備的全球市場:各用途

  • 簡介
  • 研究
  • 臨床、診斷
  • 其他

第9章 生命科學設備的全球市場:各終端用戶

  • 簡介
  • 細胞測量
    • 研究機關
    • 醫院、診斷實驗室
    • 醫藥品、生物科技企業
    • 其他
  • 離心機
    • 醫院
    • 醫藥品、生物科技企業
    • 學術、研究機關
  • 層析法
    • 醫藥品企業、CRO
    • 生物科技&生物醫藥品企業
    • 學術研究實驗室
    • 農業 & 食品產業
    • 環境檢驗
    • 其他
  • 電泳
    • 學術機構
    • 醫藥品、生物科技企業
    • 研究機關
    • 醫院、診斷中心
  • 流式細胞技術
    • 醫藥品、生物科技企業
    • 醫學系、學術機構
    • 醫院
    • 研究機關
    • 臨床檢驗實驗室
  • 免疫檢測
    • 醫院
    • 臨床實驗室
    • 醫藥品、CRO、生物科技企業
    • 血庫
    • 學術研究中心
    • 其他
  • 液體處理機器人工學
    • 醫藥品、生物科技企業
    • 研究機關
    • 醫院、私人實驗室
    • 學術機構
  • 顯微鏡
    • 學術機構
    • 產業
    • 其他
  • 次世代定序
    • 研究中心、學術&政府機關
    • 醫院、診療所
    • 醫藥品、生物科技企業
    • 其他
  • PCR
    • 醫院、診斷中心
    • 研究實驗室、學術機構
    • 醫藥品、生物科技企
    • 臨床研究機關
    • 鑑別實驗室
  • 光譜學
    • 醫藥品企業、CRO、生物科技企業
    • 食品、飲料產業
    • 環境檢驗
    • 工業化學
    • 學術機構
    • 其他
  • 西方墨點法
    • 研究機關
    • 醫藥品、生物科技企業
    • 診斷實驗室
  • 其他技術
    • 醫藥品、CRO、生物科技企業
    • 研究實驗室
    • 學術機構
    • 其他

第10章 生命科學設備的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第11章 競爭環境

  • 簡介
  • 策略性概要
  • 競爭情形、趨勢
    • 產品的投入、強化、展示
    • 協定、聯盟、合作
    • 擴張
    • M&A
    • 其他

第12章 企業簡介

  • 簡介
  • AGILENT TECHNOLOGIES, INC.
  • DANAHER CORPORATION
  • PERKINELMER, INC.
  • 島津製作所
  • THERMO FISHER SCIENTIFIC, INC.
  • BECTON, DICKINSON AND COMPANY
  • BIO-RAD LABORATORIES, INC.
  • BRUKER CORPORATION
  • F. HOFFMANN-LA ROCHE LTD.
  • WATERS CORPORATION

第13章 附錄

目錄
Product Code: AST 4499

The global life science instrumentation market is estimated to grow at a CAGR of 6.8% from 2016 to 2021, to reach USD 64.52 billion by 2021. Factors such as increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are fueling the growth of life science instrumentation market. On the other hand, presence of alternative analytical technologies, high cost of instruments, and dearth of skilled professionals are some of the key factors limiting the growth of the global life science instrumentation market.

Based on the type of technology, the spectroscopy technology segment is expected to account for the largest share of the global life science instrumentation market in 2016. The increasing use of spectroscopy instruments in the drug safety process is stimulating the growth of the spectroscopy market. In addition, the increasing use of spectroscopy in combination with other technologies, such as chromatography, in various applications is also driving the growth of this market.

Geographically, North America commands the largest share of the global life science instrumentation market in 2016, followed by Europe. The life science instrumentation market in North America is primarily driven by the stringent drug development regulations; public and private funding for life science research activities; growing number of metabolomics research studies in the U.S.; and a significant number of conferences, symposia, and seminars held in this region related to analytical technologies.

The global life science instrumentation market is highly competitive, with a large number of global and local players. As of 2016, the global life science instrumentation market was dominated by Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), and Thermo Fisher Scientific, Inc. (U.S.). Product launches, enhancements, and showcases; and partnerships, agreements, and collaborations are the major strategies adopted by market players to achieve growth in the life science instrumentation market.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis -industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the life science instrumentation market, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios and services offered by the major players in the life science instrumentation market. The report analyzes the life science instrumentation market based on the type of technology, application, and end user, across geographies
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the life science instrumentation market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various life science instrumentation systems across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the life science instrumentation market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the life science instrumentation market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS COVERED
    • 1.3.1. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Breakdown of primaries
      • 2.2.2.1. Key Data from Primary Sources
  • 2.3. MARKET SIZE ESTIMATION
      • 2.3.1.1. Bottom-up approach
      • 2.3.1.2. Top-down approach
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2016
  • 4.3. LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION (2016 VS 2021)
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE LIFE SCIENCE INSTRUMENTATION MARKET, 2016
  • 4.5. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing spending on pharmaceutical R&D across the globe
      • 5.3.1.2. Growing food safety concerns
      • 5.3.1.3. Technological advancements in analytical devices
      • 5.3.1.4. Growth in funding for research
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High cost of instruments
      • 5.3.2.2. Presence of alternative technologies
      • 5.3.2.3. Dearth of skilled professionals
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging markets offer lucrative growth opportunities
      • 5.3.3.2. Rising demand of analytical instruments with growing research activities in proteomics
      • 5.3.3.3. Increasing demand from various industries
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Inadequate infrastructure for research in emerging countries
      • 5.3.4.2. Survival of small players

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. MARKET INDICATORS
    • 6.3.1. INCREASING R&D SPENDING IN THE PHARMACEUTICAL AND BIOTECH SECTORS
  • 6.4. INDUSTRY TRENDS
    • 6.4.1. RISING FOCUS OF MARKET PLAYERS TOWARDS THE DEVELOPMENT OF MINIATURIZED INSTRUMENTS
    • 6.4.2. INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES
    • 6.4.3. TIE-UPS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS
  • 6.5. PORTER'S FIVE FORCES ANALYSIS
    • 6.5.1. THREAT OF NEW ENTRANTS
    • 6.5.2. THREAT FROM SUBSTITUTES
    • 6.5.3. BARGAINING POWER OF SUPPLIERS
    • 6.5.4. BARGAINING POWER OF BUYERS
    • 6.5.5. INTENSITY OF COMPETITIVE RIVALRY

7. LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SPECTROSCOPY
    • 7.2.1. DRIVERS
      • 7.2.1.1. Atomic spectroscopy to aid in drug safety process
    • 7.2.2. RESTRAINTS
      • 7.2.2.1. High costs
    • 7.2.3. SPECTROSCOPY MARKET, BY TYPE
      • 7.2.3.1. Molecular Spectroscopy
        • 7.2.3.1.1. Market Share Analysis, By Key Player
      • 7.2.3.2. Mass spectrometry
        • 7.2.3.2.1. Market Share Analysis, By Key Player
      • 7.2.3.3. Atomic Spectroscopy
        • 7.2.3.3.1. Market Share Analysis, By Key Player
  • 7.3. CHROMATOGRAPHY
    • 7.3.1. DRIVERS
      • 7.3.1.1. New international GMP & GDP certification for pharmaceutical excipients (North America & Europe): EXCiPACT
      • 7.3.1.2. Industry support to research laboratories and academic institutes
      • 7.3.1.3. Rise in government investments for chromatography technologies
      • 7.3.1.4. Growing importance of chromatography tests in drug approvals
    • 7.3.2. RESTRAINTS
      • 7.3.2.1. High cost of equipment
    • 7.3.3. CHROMATOGRAPHY MARKET, BY TYPE
      • 7.3.3.1. Liquid Chromatography (LC) Systems
      • 7.3.3.2. Gas Chromatography (GC) Systems
      • 7.3.3.3. Supercritical fluid chromatography (SFC) systems
      • 7.3.3.4. Thin-layer chromatography (TLC) SYSTEMS
    • 7.3.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.4. MICROSCOPY
    • 7.4.1. DRIVERS
      • 7.4.1.1. Rising focus on nanotechnology
      • 7.4.1.2. Public-private investments for the development of advanced microscopes
      • 7.4.1.3. Technological advancements
    • 7.4.2. RESTRAINTS
      • 7.4.2.1. High cost of advanced microscopes
    • 7.4.3. MICROSCOPY MARKET, BY TYPE
      • 7.4.3.1. Optical microscopy
        • 7.4.3.1.1. Market share analysis, By key player
      • 7.4.3.2. Electron microscopy
        • 7.4.3.2.1. Market share analysis, By key player
      • 7.4.3.3. Scanning probe microscopy
        • 7.4.3.3.1. Market share analysis, By key player
      • 7.4.3.4. Confocal microscopy
        • 7.4.3.4.1. Market share analysis, By key player
  • 7.5. PCR
    • 7.5.1. DRIVERS
      • 7.5.1.1. Rising incidences of infectious diseases and genetic disorders
      • 7.5.1.2. Technological advancements
    • 7.5.2. RESTRAINTS
      • 7.5.2.1. High device costs associated with dPCR
      • 7.5.2.2. Technical limitations of qPCR and dPCR
    • 7.5.3. PCR MARKET, BY TYPE
      • 7.5.3.1. qPCR
        • 7.5.3.1.1. qPCR Market Share Analysis (2015)
      • 7.5.3.2. Digital PCR (dPCR)
        • 7.5.3.2.1. dPCR Market Share Analysis (2015)
  • 7.6. FLOW CYTOMETRY
    • 7.6.1. DRIVERS
      • 7.6.1.1. Technological advancements in flow cytometry instruments
      • 7.6.1.2. Growing adoption of flow cytometry techniques in research activities
    • 7.6.2. RESTRAINTS
      • 7.6.2.1. High cost of instruments
      • 7.6.2.2. Lack of awareness and dearth of training
    • 7.6.3. FLOW CYTOMETRY MARKET, BY TYPE
      • 7.6.3.1. Cell-based flow cytometry
      • 7.6.3.2. Bead-based flow cytometry
    • 7.6.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.7. IMMUNOASSAYS
    • 7.7.1. DRIVERS
      • 7.7.1.1. Rising incidence of chronic and infectious diseases in emerging economies
      • 7.7.1.2. Sensitivity, low cost, and rapid analysis offered by immunoassays
      • 7.7.1.3. Increasing health awareness
    • 7.7.2. RESTRAINTS
      • 7.7.2.1. Low detection restricts adoption of immunoassay tests
    • 7.7.3. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.8. LIQUID HANDLING AND ROBOTICS
    • 7.8.1. DRIVERS
      • 7.8.1.1. Rising labor costs driving the need for automation
      • 7.8.1.2. Technological advancements to boost the adoption of liquid handling and robotics systems
    • 7.8.2. RESTRAINTS
      • 7.8.2.1. Reluctance of small and medium-sized labs towards the adoption of automation
    • 7.8.3. LIQUID HANDLING MARKET, BY TYPE
      • 7.8.3.1. Automatic liquid handling
      • 7.8.3.2. Manual liquid handling
    • 7.8.4. STANDALONE ROBOTS MARKET, BY TYPE
      • 7.8.4.1. Robotic arms
      • 7.8.4.2. Track robot systems
  • 7.9. CENTRIFUGES
    • 7.9.1. DRIVERS
      • 7.9.1.1. Technological advancements
      • 7.9.1.2. Increasing biopharmaceutical research activities
    • 7.9.2. RESTRAINTS
      • 7.9.2.1. Long equipment lifespan leads to low sales of centrifuges
    • 7.9.3. CENTRIFUGES MARKET, BY TYPE
      • 7.9.3.1. Microcentrifuges
      • 7.9.3.2. Multipurpose Centrifuges
      • 7.9.3.3. Floor-standing Centrifuges
      • 7.9.3.4. Ultracentrifuges
    • 7.9.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.10. ELECTROPHORESIS
    • 7.10.1. DRIVERS
      • 7.10.1.1. Increasing government funding for research on electrophoresis technique
      • 7.10.1.2. Growing number of industry-academic research collaborations
      • 7.10.1.3. Growing use of capillary electrophoresis (CE) with mass spectroscopy (MS)
    • 7.10.2. RESTRAINTS
      • 7.10.2.1. Presence of alternative technologies offering better efficiency & results
      • 7.10.2.2. Time-consuming operations and limited sample analysis
    • 7.10.3. ELECTROPHORESIS MARKET, BY TYPE
      • 7.10.3.1. Gel electrophoresis systems
      • 7.10.3.2. Capillary electrophoresis systems
    • 7.10.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.11. CELL COUNTING
    • 7.11.1. DRIVERS
      • 7.11.1.1. Growing application in diagnosis of cancer and AIDS
      • 7.11.1.2. Corporate & government funding and investments for cell-based research
      • 7.11.1.3. Development of enhanced informatics solutions and improved image analysis instruments
    • 7.11.2. RESTRAINTS
      • 7.11.2.1. High prices of advanced cell counting systems
      • 7.11.2.2. Reluctance among researchers to use advanced cell counting techniques
    • 7.11.3. CELL COUNTING MARKET, BY TYPE
      • 7.11.3.1. Automated Cell Counters
      • 7.11.3.2. Hemocytometers and Manual Cell Counters
    • 7.11.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.12. NEXT-GENERATION SEQUENCING (NGS)
    • 7.12.1. DRIVERS
      • 7.12.1.1. Focus on technological Advancements in Sequencing Platforms
      • 7.12.1.2. Increasing Applications of NGS
      • 7.12.1.3. Conferences and Workshops Increasing Awareness on NGS Products and Services
      • 7.12.1.4. Growing Partnerships and Collaborations
    • 7.12.2. RESTRAINTS
      • 7.12.2.1. Accuracy & Standardization Concerns in Diagnostic Testing
    • 7.12.3. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.13. WESTERN BLOTTING
    • 7.13.1. DRIVERS
      • 7.13.1.1. Technological advancements and instrument automation
      • 7.13.1.2. Use of western blotting for antibody validation
    • 7.13.2. RESTRAINTS
      • 7.13.2.1. High cost of primary antibodies
      • 7.13.2.2. Emergence of alternative technologies
    • 7.13.3. WESTERN BLOTTING MARKET, BY TYPE
      • 7.13.3.1. Semi-automated Instruments
      • 7.13.3.2. Automated Instruments
      • 7.13.3.3. Manual Instruments
    • 7.13.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 7.14. OTHER TECHNOLOGIES
    • 7.14.1. LABORATORY FREEZERS
      • 7.14.1.1. Freezers
      • 7.14.1.2. Refrigerators
      • 7.14.1.3. Cryopreservation systems
    • 7.14.2. HEAT STERILIZATION
      • 7.14.2.1. Moist Heat Sterilization (Autoclaves)
      • 7.14.2.2. Dry Heat
    • 7.14.3. MICROPLATE SYSTEMS
      • 7.14.3.1. Microplate Readers
      • 7.14.3.2. Microplate Dispensers
      • 7.14.3.3. Microplate Washers
    • 7.14.4. LABORATORY BALANCES
    • 7.14.5. COLORIMETERS
    • 7.14.6. INCUBATORS
    • 7.14.7. FUME HOODS

8. LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. RESEARCH APPLICATIONS
  • 8.3. CLINICAL AND DIAGNOSTIC APPLICATIONS
  • 8.4. OTHER APPLICATIONS

9. LIFE SCIENCE INSTRUMENTATION MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. CELL COUNTING
    • 9.2.1. RESEARCH INSTITUTIONS
    • 9.2.2. HOSPITALS AND DIAGNOSTIC LABORATORIES
    • 9.2.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.2.4. OTHER END USERS
  • 9.3. CENTRIFUGES
    • 9.3.1. HOSPITALS
    • 9.3.2. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
    • 9.3.3. ACADEMIC AND RESEARCH INSTITUTES
  • 9.4. CHROMATOGRAPHY
    • 9.4.1. PHARMACEUTICAL COMPANIES AND CROS
    • 9.4.2. BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES
    • 9.4.3. ACADEMIC RESEARCH LABORATORIES
    • 9.4.4. AGRICULTURE & FOOD INDUSTRY
    • 9.4.5. ENVIRONMENTAL TESTING
    • 9.4.6. OTHER END USERS
  • 9.5. ELECTROPHORESIS
    • 9.5.1. ACADEMIC INSTITUTIONS
    • 9.5.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.5.3. RESEARCH ORGANIZATIONS
    • 9.5.4. HOSPITALS AND DIAGNOSTIC CENTERS
  • 9.6. FLOW CYTOMETRY
    • 9.6.1. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.6.2. MEDICAL SCHOOLS AND ACADEMIC INSTITUTIONS
    • 9.6.3. HOSPITALS
    • 9.6.4. RESEARCH INSTITUTES
    • 9.6.5. CLINICAL TESTING LABS
  • 9.7. IMMUNOASSAY
    • 9.7.1. HOSPITALS
    • 9.7.2. CLINICAL LABORATORIES
    • 9.7.3. PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES
    • 9.7.4. BLOOD BANKS
    • 9.7.5. ACADEMIC RESEARCH CENTERS
    • 9.7.6. OTHER END USERS
  • 9.8. LIQUID HANDLING AND ROBOTICS
    • 9.8.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
    • 9.8.2. RESEARCH INSTITUTES
    • 9.8.3. HOSPITALS AND PRIVATE LABS
    • 9.8.4. ACADEMIC INSTITUTES
  • 9.9. MICROSCOPY
    • 9.9.1. ACADEMIC INSTITUTES
    • 9.9.2. INDUSTRIES
    • 9.9.3. OTHER END USERS
  • 9.10. NEXT-GENERATION SEQUENCING
    • 9.10.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
    • 9.10.2. HOSPITALS AND CLINICS
    • 9.10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.10.4. OTHER END USERS
  • 9.11. PCR
    • 9.11.1. HOSPITALS AND DIAGNOSTIC CENTERS
    • 9.11.2. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 9.11.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.11.4. CLINICAL RESEARCH ORGANIZATIONS
    • 9.11.5. FORENSIC LABORATORIES
  • 9.12. SPECTROSCOPY
    • 9.12.1. PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES
    • 9.12.2. FOOD AND BEVERAGE INDUSTRY
    • 9.12.3. ENVIRONMENTAL TESTING
    • 9.12.4. INDUSTRIAL CHEMISTRY
    • 9.12.5. ACADEMIC INSTITUTIONS
    • 9.12.6. OTHER END USERS
  • 9.13. WESTERN BLOTTING
    • 9.13.1. RESEARCH INSTITUTES
    • 9.13.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.13.3. DIAGNOSTIC LABORATORIES
  • 9.14. OTHER TECHNOLOGIES
    • 9.14.1. PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES
    • 9.14.2. RESEARCH LABORATORIES
    • 9.14.3. ACADEMIC INSTITUTIONS
    • 9.14.4. OTHERS END USERS

10. LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. FUNDING IN MEDICAL RESEARCH MAY DEVELOP NEW APPLICATION AREAS FOR ANALYTICAL TECHNOLOGIES
    • 10.2.2. STRINGENT REGULATIONS DRIVING THE USE OF ANALYTICAL INSTRUMENTS IN DRUG DEVELOPMENT
    • 10.2.3. GROWING METABOLOMICS RESEARCH IN THE U.S.
    • 10.2.4. CONFERENCES, DISCUSSIONS, SYMPOSIUMS, & SEMINARS
  • 10.3. EUROPE
    • 10.3.1. PUBLIC-PRIVATE INVESTMENTS IN R&D ACTIVITIES
    • 10.3.2. RISING AWARENESS ON ADVANCED ANALYTICAL INSTRUMENTS
    • 10.3.3. DEVELOPING PHARMACEUTICAL SECTOR IN RUSSIA
  • 10.4. ASIA-PACIFIC
    • 10.4.1. STRATEGIC EXPANSIONS BY KEY MARKET PLAYERS IN EMERGING ASIAN COUNTRIES
    • 10.4.2. RISING CROP RESEARCH STUDIES IN ASIA
    • 10.4.3. GOVERNMENT INVESTMENTS IN CHINESE BIOMEDICAL INDUSTRY DRIVING THE DEMAND FOR ANALYTICAL INSTRUMENTS
    • 10.4.4. SINGAPORE, AN IMPORTANT MARKET FOR LIFE SCIENCE INSTRUMENTATION
    • 10.4.5. INCREASING CONFERENCES, EXHIBITIONS, & MEETINGS ON ANALYTICAL INSTRUMENTS
  • 10.5. REST OF THE WORLD
    • 10.5.1. FLOURISHING BIOTECHNOLOGY & PHARMACEUTICAL MARKETS IN BRAZIL AND MEXICO
    • 10.5.2. INCREASING R&D FUNDING IN THE LATIN AMERICAN REGION
    • 10.5.3. HIGH PREVALENCE OF HIV IN AFRICAN REGION

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. STRATEGIC OVERVIEW
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. PRODUCT LAUNCHES, ENHANCEMENTS, AND SHOWCASE
    • 11.3.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.3.3. EXPANSION
    • 11.3.4. MERGERS & ACQUISITIONS
    • 11.3.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. AGILENT TECHNOLOGIES, INC.
  • 12.3. DANAHER CORPORATION
  • 12.4. PERKINELMER, INC.
  • 12.5. SHIMADZU CORPORATION
  • 12.6. THERMO FISHER SCIENTIFIC, INC.
  • 12.7. BECTON, DICKINSON AND COMPANY
  • 12.8. BIO-RAD LABORATORIES, INC.
  • 12.9. BRUKER CORPORATION
  • 12.10. F. HOFFMANN-LA ROCHE LTD.
  • 12.11. WATERS CORPORATION

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: MARKET CONSOLIDATION
  • TABLE 2: LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 3: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR SPECTROSCOPY, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 4: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR SPECTROSCOPY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: MOLECULAR SPECTROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: MASS SPECTROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: ATOMIC SPECTROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR CHROMATOGRAPHY, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR CHROMATOGRAPHY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: LIQUID CHROMATOGRAPHY SYSTEMS DIFFERENTIATION
  • TABLE 11: LIQUID CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: GAS CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: SUPERCRITICAL FLUID CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: THIN-LAYER CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL MICROSCOPY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 16: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR MICROSCOPY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: OPTICAL MICROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: ELECTRON MICROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: SCANNING PROBE MICROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: CONFOCAL MICROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR PCR, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 22: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR PCR, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: QPCR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: DPCR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR FLOW CYTOMETRY, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 26: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR FLOW CYTOMETRY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: CELL-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: BEAD-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR IMMUNOASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL LIQUID HANDLING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL STANDALONE ROBOTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 32: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR LIQUID HANDLING AND ROBOTICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: AUTOMATED LIQUID HANDLING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: MANUAL LIQUID HANDLING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: ROBOTIC ARMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: TRACK ROBOT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR CENTRIFUGES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 38: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR CENTRIFUGES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: MICROCENTRIFUGES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: MULTIPURPOSE CENTRIFUGES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: FLOOR-STANDING CENTRIFUGES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: ULTRACENTRIFUGES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR ELECTROPHORESIS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR ELECTROPHORESIS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: GEL ELECTROPHORESIS SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: CAPILLARY ELECTROPHORESIS SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR CELL COUNTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR CELL COUNTING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: AUTOMATED CELL COUNTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: HEMOCYTOMETERS AND MANUAL CELL COUNTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: NGS PLATFORMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: LIST OF SEQUENCING PLATFORMS LAUNCHED, 2015-2016
  • TABLE 53: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR WESTERN BLOTTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR WESTERN BLOTTING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: SEMI-AUTOMATED INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: AUTOMATED INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: MANUAL INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 161  
  • TABLE 58: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR OTHER TECHNOLOGIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: LIFE SCIENCE INSTRUMENTATION MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: LABORATORY FREEZERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: LABORATORY FREEZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: HEAT STERILIZATION MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: HEAT STERILIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 64: STERILIZATION TEMPERATURE BANDS, HOLDING TIMES, AND PRESSURES FOR STEAM STERILIZATION
  • TABLE 65: DRYING CYCLES RECOMMENDED AS PER BP (BRITISH PHARMACOPEIA), 1988
  • TABLE 66: MICROPLATE SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: MICROPLATE SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 68: LABORATORY BALANCES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 69: COLORIMETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 70: INCUBATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 71: FUME HOODS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 72: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 73: GLOBAL CELL COUNTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 74: GLOBAL CENTRIFUGES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: FUNDING FOR RESEARCH
  • TABLE 76: GLOBAL CHROMATOGRAPHY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 77: GLOBAL ELECTROPHORESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 78: GLOBAL FLOW CYTOMETRY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: GLOBAL LIQUID HANDLING AND ROBOTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 81: GLOBAL MICROSCOPY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 82: GLOBAL NGS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 83: GLOBAL PCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 84: GLOBAL SPECTROSCOPY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 85: GLOBAL WESTERN BLOTTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 86: GLOBAL OTHER TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 88: NORTH AMERICA: LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 89: EUROPE: LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 90: ASIA-PACIFIC: LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 91: ROW: LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 92: PRODUCT LAUNCHES, ENHANCEMENTS, AND SHOWCASE, 2016
  • TABLE 93: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016
  • TABLE 94: EXPANSIONS, 2015-2016
  • TABLE 95: MERGERS & ACQUISITIONS, 2013-2015
  • TABLE 96: OTHER DEVELOPMENTS, 2013-2014

LIST OF FIGURES

  • FIGURE 1: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: LIFE SCIENCE INSTRUMENTATION MARKET: DATA TRIANGULATION
  • FIGURE 4: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET, 2016 (USD MILLION)
  • FIGURE 5: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 6: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: NORTH AMERICA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE IN THE GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 8: INCREASING PHARMACEUTICAL R&D EXPENDITURE IS DRIVING GROWTH IN THE LIFE SCIENCE INSTRUMENTATION MARKET
  • FIGURE 9: SPECTROSCOPY DOMINATED THE LIFE SCIENCE INSTRUMENTATION MARKET IN 2016
  • FIGURE 10: NGS IS EXPECTED TO GROW AT THE FASTEST RATE DURING THE FORECAST PERIOD
  • FIGURE 11: RESEARCH APPLICATIONS SEGMENT TO CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: ASIA-PACIFIC HOLDS LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 14: LIFE SCIENCE INSTRUMENTATION MARKET SEGMENTATION
  • FIGURE 15: LIFE SCIENCE INSTRUMENTATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: INCREASING SPENDING ON PHARMACEUTICAL R&D IS PROPELLING THE MARKET GROWTH
  • FIGURE 17: HIGH COST OF INSTRUMENTS LIMITS THEIR ADOPTION AMONG LOW-BUDGET END USERS
  • FIGURE 18: EMERGING MARKETS OFFER LUCRATIVE GROWTH OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 19: INADEQUATE INFRASTRUCTURE FOR RESEARCH IN EMERGING COUNTRIES-A MAJOR MARKET CHALLENGE
  • FIGURE 20: VALUE CHAIN OF LIFE SCIENCE INSTRUMENTATION INDUSTRY
  • FIGURE 21: INCREASING R&D INVESTMENTS IN THE PHARMA AND BIOTECH INDUSTRIES ARE BOOSTING THE GROWTH OF THE LIFE SCIENCE INSTRUMENTS MARKET
  • FIGURE 22: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 23: LIFE SCIENCE INSTRUMENTATION MARKET SEGMENTATION, BY TECHNOLOGY
  • FIGURE 24: LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2016 (USD MILLION)
  • FIGURE 25: SPECTROSCOPY SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 26: GLOBAL MOLECULAR SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 27: GLOBAL MASS SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 28: GLOBAL ATOMIC SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 29: CHROMATOGRAPHY SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 30: GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 31: MICROSCOPY SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 32: GLOBAL OPTICAL MICROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 33: GLOBAL ELECTRON MICROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 34: GLOBAL SCANNING PROBE MICROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 35: GLOBAL CONFOCAL MICROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 36: PCR SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 37: MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
  • FIGURE 38: MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
  • FIGURE 39: FLOW CYTOMETRY SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 40: GLOBAL FLOW CYTOMETRY MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 41: IMMUNOASSAYS SEGMENT TO GROW AT THE HIGHEST CAGR IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 42: GLOBAL PREVALENCE OF HIV INFECTIONS AMONG ADULTS AGED 15 TO 49 YEARS (2014)
  • FIGURE 43: GLOBAL IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 44: LIQUID HANDLING AND ROBOTICS SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 45: CENTRIFUGES SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 46: GLOBAL CENTRIFUGES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 47: ELECTROPHORESIS SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 48: GLOBAL ELECTROPHORESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 49: CELL COUNTING SEGMENT TO REGISTER HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 50: GLOBAL CELL COUNTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 51: NGS PLATFORMS SEGMENT TO REGISTER HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 52: GLOBAL NGS PLATFORMS MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 53: WESTERN BLOTTING SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 54: GLOBAL WESTERN BLOTTING MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 55: OTHER TECHNOLOGIES SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 56: LIFE SCIENCE INSTRUMENTATION MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 57: RESEARCH APPLICATION ACCOUNTS FOR THE LARGEST APPLICATION SEGMENT OF THE LIFE SCIENCE INSTRUMENTATION MARKET IN 2016
  • FIGURE 58: RESEARCH INSTITUTIONS HOLD THE LARGEST SHARE OF THE GLOBAL CELL COUNTING MARKET
  • FIGURE 59: HOSPITALS HOLD THE LARGEST SHARE OF THE GLOBAL CENTRIFUGES MARKET
  • FIGURE 60: PHARMACEUTICAL COMPANIES AND CROS HOLD THE LARGEST SHARE OF THE GLOBAL CHROMATOGRAPHY MARKET
  • FIGURE 61: ACADEMIC INSTITUTIONS HOLD THE LARGEST SHARE OF THE GLOBAL ELECTROPHORESIS MARKET
  • FIGURE 62: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES HOLD THE LARGEST SHARE OF THE GLOBAL FLOW CYTOMETRY MARKET
  • FIGURE 63: HOSPITALS HOLD THE LARGEST SHARE OF THE GLOBAL IMMUNOASSAY MARKET
  • FIGURE 64: BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES HOLD THE LARGEST SHARE OF THE GLOBAL LIQUID HANDLING AND ROBOTICS MARKET
  • FIGURE 65: ACADEMIC INSTITUTES HOLD THE LARGEST SHARE OF THE GLOBAL MICROSCOPY MARKET
  • FIGURE 66: RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES HOLD THE LARGEST SHARE OF GLOBAL NGS MARKET
  • FIGURE 67: HOSPITALS AND DIAGNOSTIC CENTERS HOLD THE LARGEST SHARE OF THE GLOBAL PCR MARKET
  • FIGURE 68: PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES HOLD THE LARGEST SHARE OF THE GLOBAL SPECTROSCOPY MARKET
  • FIGURE 69: RESEARCH INSTITUTES HOLD THE LARGEST SHARE OF GLOBAL WESTERN BLOTTING MARKET
  • FIGURE 70: PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES HOLD THE LARGEST SHARE OF GLOBAL OTHER TECHNOLOGIES MARKET
  • FIGURE 71: LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION
  • FIGURE 72: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 73: NORTH AMERICA: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT (2016)
  • FIGURE 74: EUROPE: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT (2016)
  • FIGURE 75: ASIA-PACIFIC: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT (2016)
  • FIGURE 76: ROW: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT (2016)
  • FIGURE 77: LEADING MARKET PLAYERS ADOPTED PRODUCT LAUNCHES, ENHANCEMENTS, AND PRODUCT SHOWCASE AS THEIR KEY GROWTH STRATEGY FROM 2015 TO 2016
  • FIGURE 78: PRODUCT LAUNCHES, ENHANCEMENTS, AND SHOWCASE-MAJORLY ADOPTED GROWTH STRATEGIES DURING 2013 TO 2016
  • FIGURE 79: FINANCIAL PERFORMANCE OF THE TOP 5 MARKET PLAYERS IN 2015
  • FIGURE 80: COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC.
  • FIGURE 81: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 82: COMPANY SNAPSHOT: PERKINELMER, INC.
  • FIGURE 83: COMPANY SNAPSHOT: SHIMADZU CORPORATION
  • FIGURE 84: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 85: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
  • FIGURE 86: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC.
  • FIGURE 87: COMPANY SNAPSHOT: BRUKER CORPORATION
  • FIGURE 88: COMPANY SNAPSHOT: ROCHE DIAGNOSTICS.
  • FIGURE 89: COMPANY SNAPSHOT: WATERS CORPORATION
Back to Top